Clinical Trial Update: Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3) [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial evaluating new treatment schedules in treatment-naive patients with genotype 3 hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Casa Sollievo della Sofferenza IRCCS | Conditions: Chronic Hepatitis | Phase 3 | Status: COMPLETED